There has been an association of follicular thyroid cancer (FTC) in mouse models with some specific thyroid hormone receptor beta (THRB) mutations (15, 16) which can cause thyroid hormone resistance syndrome (17). Here, THRB is linked to thyroid hormone resistance syndrome.